| RRC ID |
78887
|
| 著者 |
Chen CY, Ueha S, Ishiwata Y, Shichino S, Yokochi S, Yang D, Oppenheim JJ, Ogiwara H, Deshimaru S, Kanno Y, Aoki H, Ogawa T, Shibayama S, Matsushima K.
|
| タイトル |
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
|
| ジャーナル |
Cancer Immunol Res
|
| Abstract |
The expansion of intratumoral stem-like/progenitor exhausted CD8+ T (Tstem/Tpex) cells provides a potential approach to improve the therapeutic efficacy of immune checkpoint blockade (ICB). Thus, here we demonstrate a strategy to facilitate Tstem/Tpex cell expansion by combining an alarmin high-mobility group nucleosome binding domain 1 (HMGN1) peptide with programmed death-ligand 1 (PD-L1) blockade. The antitumor effects of HMGN1, anti-PD-L1, and their combined treatment were monitored in the B16F10, LLC, Colon26, or EO771 tumor-bearing mice. The comprehensive immunologic analyses, such as high-dimensional flow cytometry, transcriptome analysis, and single-cell RNA-sequencing (scRNA-seq), were used to investigate the cellular and molecular mechanisms of antitumor immune responses after treatments. We identified the immunostimulatory domain (EPKRR SARLS AKPPA KVEAK PKK) on HMGN1 and synthesized this domain as a therapeutic peptide (minP1). Combined treatment with minP1 and PD-L1 blockade induced durable tumor regression in tumor-bearing mice. minP1 increased the number of intratumoral mature DCs enriched in immunoregulatory molecules (mregDC) and enhanced their MHC class I antigen-presenting program. minP1 also synergized with PD-L1 blockade in augmenting intratumoral Tstem/Tpex cell number. Analysis of our scRNA-seq dataset by CellPhonDB suggested potential interactions between mregDCs and Tstem/Tpex cells in tumors. Our results indicate that HMGN1 peptide (minP1) serves as an immunoadjuvant to promote effective anti-PD-L1 immunotherapy with increased Tstem/Tpex cells in tumors.
|
| 巻・号 |
9(10)
|
| ページ |
1214-1228
|
| 公開日 |
2021-10-1
|
| DOI |
10.1158/2326-6066.CIR-21-0265
|
| PII |
2326-6066.CIR-21-0265
|
| PMID |
34344641
|
| PMC |
PMC10087296
|
| MeSH |
Alarmins / therapeutic use*
Animals
B7-H1 Antigen / antagonists & inhibitors*
B7-H1 Antigen / immunology
CD8-Positive T-Lymphocytes / immunology*
Cell Line, Tumor
Female
HMGN1 Protein / genetics
HMGN1 Protein / therapeutic use*
Immunotherapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasms / immunology
Neoplasms / therapy*
|
| リソース情報 |
| ヒト・動物細胞 |
Colon-26(RCB2657) |
